Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers

SIMPLE SUMMARY: Angiogenesis, defined as the abnormal development of new blood vessels in cancer, is a key component of cancer development. Clinical trials have proven that angiogenesis blockers can be effective in halting cancer growth across numerous types of gynecologic cancers. This review discu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasherman, Lawrence, Liu, Shiru (Lucy), Karakasis, Katherine, Lheureux, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908988/
https://www.ncbi.nlm.nih.gov/pubmed/35267430
http://dx.doi.org/10.3390/cancers14051122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908988/
https://www.ncbi.nlm.nih.gov/pubmed/35267430
http://dx.doi.org/10.3390/cancers14051122

Ejemplares similares